COVID-19 Vaccine Education at the Point of COVID-19 Testing for Vaccine Refusal
Study Summary
This trial will test a new way of educating people about vaccines in order to get more people to get the vaccine, specifically in vulnerable communities in Louisiana.
- Coronavirus
- Vaccine Refusal
- Vaccine Hesitancy
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 1 Secondary · Reporting Duration: 9 months intervention
Trial Safety
Safety Progress
Trial Design
1 Treatment Group
Participants Which Receive COVID-19 Vaccine Education at the Point of COVID-19 T...
1 of 1
Experimental Treatment
375 Total Participants · 1 Treatment Group
Primary Treatment: COVID-19 Vaccine Education at the Point of COVID-19 Testing · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 99 · All Participants · 2 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Are new participants still being sought to take part in this clinical experiment?
"Per the information listed on clinicaltrials.gov, this medical study is no longer in search of applicants. It was first published on January 1st 2022 and was last revised June 24th 2021; however, there are currently 1055 other trials actively searching for participants at this time." - Anonymous Online Contributor
Can individuals aged eighty-five and over participate in this clinical trial?
"The eligibility requirements of this trial indicate that the minimum age for participation is 18, while the maximum age applicable to participants is 99." - Anonymous Online Contributor
What type of participant is ideal for this research endeavor?
"This clinical trial is accepting participants with vaccine hesitancy who range from 18 to 99 years old. 375 individuals have been recruited so far, and the team plans to continue recruiting more." - Anonymous Online Contributor